These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33867268)

  • 1. In vitro activities and spectrum of lascufloxacin（KRP-AM1977）against anaerobes.
    Tanaka K; Vu H; Hayashi M
    J Infect Chemother; 2021 Aug; 27(8):1265-1269. PubMed ID: 33867268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group.
    Yamagishi Y; Matsukawa Y; Suematsu H; Mikamo H
    Anaerobe; 2018 Dec; 54():61-64. PubMed ID: 30114441
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Goldstein EJC; Merriam CV; Citron DM
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.
    Liebetrau A; Rodloff AC; Behra-Miellet J; Dubreuil L
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3667-71. PubMed ID: 14576144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Aldridge KE
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1671-4. PubMed ID: 7979307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamic resistance profiles in Porphyromonas, Prevotella, and Parvimonas species isolated from acute endodontic infections.
    Montagner F; Jacinto RC; Correa Signoretti FG; Scheffer de Mattos V; Grecca FS; Gomes BP
    J Endod; 2014 Mar; 40(3):339-44. PubMed ID: 24565649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobes.
    Goldstein EJ; Citron DM; Vreni Merriam C; Tyrrell K; Warren Y
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2726-30. PubMed ID: 10543754
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kishii R; Yamaguchi Y; Takei M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
    Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
    Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of delafloxacin against anaerobic bacteria compared with other antimicrobials.
    Cobo F; Franco-Acosta A; Martín-Hita L; Rodríguez-Granger J; Sampedro-Martínez A; Reguera-Márquez JA; Navarro-Marí JM
    Anaerobe; 2024 Feb; 85():102816. PubMed ID: 38145709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinidazole inhibitory and cidal activity against anaerobic periodontal pathogens.
    Alou L; Giménez MJ; Manso F; Sevillano D; Torrico M; González N; Granizo JJ; Bascones A; Prieto J; Maestre JR; Aguilar L
    Int J Antimicrob Agents; 2009 May; 33(5):449-52. PubMed ID: 19097755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the in vitro activity of gemifloxacin against gram-positive and gram-negative anaerobic pathogens.
    Goldstein EJ
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():55-65. PubMed ID: 10824034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
    Wexler HM; Molitoris E; Molitoris D; Finegold SM
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2232-5. PubMed ID: 8878617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of faropenem against 579 strains of anaerobic bacteria.
    Wexler HM; Molitoris D; St John S; Vu A; Read EK; Finegold SM
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3669-75. PubMed ID: 12384389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
    Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1552-7. PubMed ID: 9210683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
    Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro activity of trospectomycin against anaerobic bacteria.
    Chisari G; Lo Bue AM; Nicoletti G
    J Chemother; 1995 Dec; 7(6):515-8. PubMed ID: 8667035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis.
    Werner H; Heizmann WR; Höflsauer M
    Infection; 1991; 19(5):377-9. PubMed ID: 1800380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
    Nenoff P; Haustein UF; Hittel N
    Chemotherapy; 2004 Oct; 50(4):196-201. PubMed ID: 15452398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.